Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501623012 | Carbidopa 25 mg and levodopa 100 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3677293011 | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46812401000001110 | Co-careldopa 25mg/100mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing levodopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa and levodopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Levodopa | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Carbidopa | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Carbidopa | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Levodopa | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has precise active ingredient | Carbidopa | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has precise active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing only carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa monohydrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Carbidopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has specific active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has specific active ingredient | Carbidopa monohydrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has specific active ingredient | Carbidopa monohydrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Carbidopa | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Co-careldopa 25mg/100mg tablet | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Kent Pharma (UK) Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Unichem Plc) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Organon Pharma (UK) Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Approved Prescription Services) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (A A H Pharmaceuticals Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (PI) (Waymade Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (PI) (Dowelhurst Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (PI) (Dowelhurst Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 90 tablet | Is pack of | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 100 tablet | Is pack of | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 90 tablet | Has VMP | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 100 tablet | Has VMP | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Lexon (UK) Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Stephar (U.K.) Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sinemet Plus 25mg/100mg tablets (Necessity Supplies Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Somex Pharma) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Bristol Laboratories Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 60 tablet | Has VMP | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 50 tablet | Has VMP | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets 30 tablet | Has VMP | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) | Is a | False | Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets